Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “EBV-positive Nasopharyngeal Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 0 results

Large-scale testing (Phase 3)UnknownNCT03656965
What this trial is testing

EBV Positive Nasopharyngeal Carcinoma Treated With Concurrent Chemo-radiotherapy With or Without Anti-Viral Drug

Who this might be right for
Drug Use for Unapproved Schedule
Kuwait Cancer Control Center 50
Early research (Phase 1)Active Not RecruitingNCT02287311
What this trial is testing

Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)

Who this might be right for
Hodgkin DiseaseNon-Hodgkin LymphomaSevere Chronic Active Epstein Barr Virus+3 more
Baylor College of Medicine 38
Very early researchUnknownNCT05654077
What this trial is testing

EBV CAR-T Cells for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
The Affiliated Hospital of Xuzhou Medical University 24
Early research (Phase 1)WithdrawnNCT00515957
What this trial is testing

Study of LMP1- and LMP2- Specific Cytotoxic T-Lymphocytes (CTL)

Who this might be right for
NASOPHARYNGEAL CARCINOMA
Baylor College of Medicine
Large-scale testing (Phase 3)Ended earlyNCT04458909
What this trial is testing

Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer

Who this might be right for
Metastatic Nasopharyngeal CarcinomaMetastatic Nasopharyngeal Keratinizing Squamous Cell CarcinomaMetastatic Nasopharyngeal Nonkeratinizing Carcinoma+8 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Looking for participantsNCT06019130
What this trial is testing

Nivolumab in Children and Adults With Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaNasopharyngeal CancerNasopharyngeal Neoplasms+1 more
German Society for Pediatric Oncology and Hematology GPOH gGmbH 57